The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Voskanyan S.E.

Burnazyan Federal Medical Biophysical Center

Chuchuev E.S.

Group of Companies «MEDSI»

Rudakov V.S.

Burnazyan Federal Medical Biophysical Center

Vidmer E.V.

Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Indications for lymph node dissection in hepatocellular carcinoma

Authors:

Voskanyan S.E., Chuchuev E.S., Rudakov V.S., Vidmer E.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2022;(6): 5‑10

DOI: 10.17116/hirurgia20220615

Read: 1375 times

Download PDF (RU)
Contact the author
Table of contents

INDICATIONS FOR LYMPH NODE DISSECTION IN HEPATOCELLULAR CARCINOMA
INDICATIONS FOR LYMPH NODE DISSECTION IN HEPATOCELLULAR CARCINOMA

To cite this article:

Voskanyan SE, Chuchuev ES, Rudakov VS, Vidmer EV. Indications for lymph node dissection in hepatocellular carcinoma. Pirogov Russian Journal of Surgery. 2022;(6):5‑10. (In Russ.)
https://doi.org/10.17116/hirurgia20220615

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

OBJECTIVE

To determine the indications for lymph node dissection in patients with hepatocellular carcinoma.

MATERIAL AND METHODS

The study included 105 patients with hepatocellular carcinoma who underwent dissection of 8, 9, 12, 13 and 16a2 groups of lymph nodes. Concomitant liver diseases were not a contraindication for lymph node dissection. Immediate and long-term treatment outcomes were retrospectively analyzed.

RESULTS

Lymph node dissection did not affect the number of postoperative complications (p=0.83) and mortality (p=0.34). The number of tumors (p=0.02) and concomitant liver diseases (p=0.05) significantly affected lymph node metastatic lesions. Metastases were found only in lymph nodes >1 cm. Metastatic lesions of lymph nodes in hepatoduodenal ligament and retropancreatic zone were the most common. However, 5 patients had metastatic lesions of aortocaval and celiac lymph nodes without metastases in hepatoduodenal ligament. Overall 5-year survival of patients with lymph node metastases after total resection was 32.4%. It is a better result compared to other treatments.

CONCLUSION

There was no significant effect of lymph node dissection on immediate postoperative results regardless concomitant pathology. Lymph node dissection is recommended for patients with a high risk of metastasis or lymph nodes metastases.

Keywords:

hepatocellular carcinoma
lymph node dissection
lymph node metastases
liver resection

Authors:

Voskanyan S.E.

Burnazyan Federal Medical Biophysical Center

Chuchuev E.S.

Group of Companies «MEDSI»

Rudakov V.S.

Burnazyan Federal Medical Biophysical Center

Vidmer E.V.

Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Received:

07.10.2021

Accepted:

08.12.2021

Close metadata

References:

  1. Julie BS, Shelby A, Kathryn EE, Katherine AM, William PL. Travel distance and overall survival in hepatocellular cancer care. The American Journal of Surgery. 2021;222(3):584-593.  https://doi.org/10.1016/j.amjsurg.2020.12.052
  2. Diamantis IT, Fabio B, Dimitrios M, Katiuscha M et all. Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients. Surgery. 2019;166(6):967-974.  https://doi.org/10.1016/j.surg.2019.08.010
  3. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK et al. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg. 2002;236:602-611.  https://doi.org/10.1097/00000658-200211000-00010
  4. Zhou XD, Tang ZY, Yang BH, Lin ZY, Ma ZC, Ye SL, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer. 2001;91:1479-1486. https://doi.org/10.1002/1097-0142(20010415)91:8<1479::aid-cncr1155>3.0.co;2-0 "> 3.0.co;2-0" target="_blank">https://doi.org/10.1002/1097-0142(20010415)91:8<1479::aid-cncr1155>3.0.co;2-0
  5. Committee on Classification of Regional Lymph Nodes of Japan Society of Clinical Oncology. Classification of Regional Lymph Nodes in Japan. Int J Clin Oncol. 2003;8:248-275.  https://doi.org/10.1007/s10147-003-0343-7
  6. Ruiz E, Pineau P, Flores C, Fernández R, Cano L, Cerapio JP, Casavilca-Zambrano S, Berrospi F, Chávez I, Roche B, Bertani S. A preoperative nomogram for predicting long-term survival after resection of large hepatocellular carcinoma (>10 cm). HPB. 2021;1365. https://doi.org/10.1016/j.hpb.2021.06.006
  7. Esnaola NF, Mirza N, Lauwers GY, et al. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg. 2003;238(5):711-719.  https://doi.org/10.1097/01.sla.0000094436.34556.ac
  8. Tateishi R, Yoshida H, Shiina S, et al. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut. 2005;54(3):419-425.  https://doi.org/10.1136/gut.2003.035055
  9. Capussotti L, Ferrero A, Vigano L, Polastri R, Tabone M. Liver resection for HCC with cirrhosis: Surgical perspectives out of EASL/AASLD guidelines. EJSO. 2009;35:11-15.  https://doi.org/10.1016/j.ejso.2007.06.005
  10. Ikai I, Arii S, Okazaki M, et all. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2007;37:676-691.  https://doi.org/10.1111/j.1872-034x.2007.00119.x
  11. Sun C. Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. J Surg Oncol. 2007;96:37-45.  https://doi.org/10.1002/jso.20772
  12. Kobayashi S, Takahachi S, Kato Y. et all. Surgical treatment of lymph node metastases from hepatocellular carcinoma. JHBP Sci. 2011;18:559-566.  https://doi.org/10.1007/s00534-011-0372-y
  13. Yang A, Xiao W, Ju W, Liao Y, Chen M, Zhu X, Wu C, He X. Prevalence and clinical significance of regional lymphadenectomy in patients with hepatocellular carcinoma. ANZ J Surg. 2019;89(4):393-398.  https://doi.org/10.1111/ans.15096
  14. Ercolani G, Grazi GL, Ravaioli M, Grigioni WF, Cescon M, Gardini A, Del Gaudio M, Cavallari A. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg. 200;239(2):202-209.  https://doi.org/10.1097/01.sla.0000109154.00020.e0
  15. Xiaohong S, Huikai L, Feng W, Ti Z, Yunlong C, Qiang L. Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma. World J Surg. 2010;34(5):1028-1033. https://doi.org/10.1007/s00268-010-0400-0
  16. Watanabe, Nakashima O, Kojiro M. Clinicopathologic study on lymph node metastasis of hepatocellular carcinoma: a retrospective study of 660 consecutive autopsy cases. Jpn J Cli Oncol. 1994;24(1):37-41.  https://doi.org/10.1093/oxfordjournals.jjco.a039672
  17. Kaczynski J, Hansson G, Wallerstedt S. Metastases in cases with hepatocellular carcinoma in relation to clinicopathologic features of the tumor. An autopsy study from a low endemic area. Acta Oncol. 1995;34(1):43-48.  https://doi.org/10.3109/02841869509093637
  18. Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D’Angelica M, DeMatteo RP, Schwartz L, Blumgart LH, Jarnagin WR. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg. 2006;244(2):260-264.  https://doi.org/10.1097/01.sla.0000217606.59625.9d
  19. Lee A, Chun Y, Conrad C, Kaseb A, Raghav K et all. Selective lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and node positivity rates. HPB. 2018;20(2):256.  https://doi.org/10.1016/j.hpb.2018.06.193
  20. Yang A, Xiao W, Ju W, Liao Y, Chen M, Zhu X, Wu C, He X, Prevalence and clinical significance of regional lymphadenectomy in patients with hepatocellular carcinoma. ANZ J Surg. 2019;89(4):393-398.  https://doi.org/10.1111/ans.15096
  21. Ishii H, Saito H. Perihepatic lymphadenopathy in chronic liver diseases. J Gastroenterol Hepatol. 2000;15(7):695-696.  https://doi.org/10.1046/j.1440-1746.2000.02208.x
  22. Olmo J, Esteban J, Maldonado L, Rodriguez F, Escudero A, Serra M, Rodrigo J. Clinical significance of abdominal lymphadenopathy in chronic liver disease. Ultrasound Med Biol. 2002;28(3):297-301.  https://doi.org/10.1016/s0301-5629(01)00514-2
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.